13th annual CHFR symposium on heart failure september 23-25, 2015 holmenkollen park hotel rica oslo, norway Wednesday September 23 Friday September 25 NORHEART seminar – open to all Bernard Gersh, Mayo Clinic, Rochester – Coronary revascularization in patients with severe left ventricular dysfunction: Is viability testing viable? Yibin Wang, University of C alifornia, Los Angeles – Blind dates in sciences; dealing with revision in peer review Stein Ørn, University of Stavanger, Norway – The taste of Olympic success Thursday September 24 Opening remarks by Cathrine M. Lofthus, Chief Executive Officer, South-Eastern Norway Regional Health Authority Moderated poster sessions Abstract submission before June 3, 2015. Registration before August 13, 2015 Brian Kobilka, Nobel Laureate, Stanford University, California – G protein coupled receptors: Challenges in drug discovery Bernard Cosyns, Universitair ziekenhuis van Brussel, Belgium – Drug-induced valvular heart disease Gerasimos Filippatos, University of Athens, Greece – Treatment of heart failure and concomitant renal failure Mark E. Anderson, Johns Hopkins University, Baltimore – Metabolism, CaMKII and heart rate Don Bers, University of California, Davis – CaMKII function and roles in heart failure and cardiac arrhythmia Christine Seidman, Harvard Medical School, Boston – Hypertrophic cardiomyopathy mutations, mechanisms, and treatment Yibin Wang, University of California, Los Angeles – Dissecting genetic basis of common forms of heart failure via systems genetics Jonathan Seidman, Harvard Medical School, Boston – Titin mutations in mice and men Helge Røsjø, Akershus University Hospital, Norway – Refining established biomarkers and developing novel biomarkers for personalized cardiovascular medicine Christie Mitchell Ballantyne, Baylor College of Medicine, Houston – Markers of subclinical myocardial injury in the Atherosclerosis Risk in the Community (ARIC) study: Is there a role for comprehensive CV risk assessment? Alessandro Cataliotti, University of Oslo, Norway – Hypertensive heart disease: A cardiac natriuretic peptide deficiency state? Scott D. Solomon, Harvard Medical School, Boston – Combined angiotensin receptor antagonism and neprilysin inhibition in heart failure: A new paradigm? NORHEART Working Group: Oslo: Geir Christensen, Mathis K Stokke, Kåre-Olav S tensløkken, Ida G Lunde, Ulla H Enger, Vidar Skulberg Tromsø: Terje Larsen, Kirsti Y trehus, Ole-Jakob How Trondheim: Ulrik Wisløff, Øyvind Ellingsen, Øivind Rognmo Bergen: Eva Gerdts, Stein Ørn, Helga Midtbø www.norheart.no Steering Committee, Center for Heart Failure Research: Stefan Agewall, Geir Øystein Andersen, Harald Arnesen, Dan Atar, Håvard Attramadal, Reidar Bjørnerheim, Thor Edvardsen, Lars Gullestad, Sandip Kanse, Finn Olav Levy, Torbjørn Omland, Jan-Bjørn Osnes, Helge Røsjø, Ole M. Sejersted, Ingebjørg Seljeflot, Ivar Sjaastad, Tor Skomedal, Otto A Smiseth, Petter Andreas Steen, Kåre-Olav Stensløkken, Kjetil Sunde, Theis Tønnessen, Leif Erik Vinge and Geir Christensen Organizing Committee: Mathis K Stokke and Geir Christensen www.heartfailure.no